CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.
Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, Chen R, Liu X, Xu H, Cai S, Chen H, Li W, Xu S, Wang L, Hu Z, Zhuang Q, Wang L, Wu K, Liu J, Ye Z, Ji JY, Wang C, Chen K.
Wang T, et al. Among authors: wang l, wang c.
Oncotarget. 2014 Nov 15;5(21):10293-306. doi: 10.18632/oncotarget.2511.
Oncotarget. 2014.
PMID: 25296973
Free PMC article.